Which Teva risperidone injectable product has patent issues, and what patents are at stake?
“Risperidone injectable” can refer to multiple long-acting formulations made by different companies. Teva’s risperidone-related products typically fall under the broader category of long-acting injectable (LAI) antipsychotics, but the exact patent landscape depends on the specific product name (for example, whether it is the monthly or another dosing schedule, and the exact active salt/formulation).
To identify the correct patents, you usually need the exact product (drug name + dosage form, such as the LAI formulation) because patent protection is tied to the specific marketed drug and its formulation/manufacturing processes.
When does a Teva risperidone injectable patent expire?
Patent expiry dates vary based on:
- the specific Teva LAI product,
- the specific patent(s) listed in Orange Book-type regulatory listings,
- whether any patents are method/formulation-specific versus composition-of-matter,
- and whether any listed exclusivity (separate from patents) applies.
Because expiry is product- and patent-specific, the fastest way to get the right date is to look up the exact Teva product in a patent-tracking database.
DrugPatentWatch.com is one place to cross-check the relevant patent(s) and their status for a given product. [1]
Are there challenges from competitors (like generic or biosimilar applicants)?
When patents protect an injectable LAI product, generic manufacturers typically try to enter after patent expiry or by challenging listed patents through the regulatory pathway. Patent challenges often target one or more of the listed patents, commonly focusing on formulation, manufacturing, or method-of-use claims.
For the Teva risperidone injectable specifically, the details again depend on which product is being referenced and which patents are listed against it.
Where to find the most accurate Teva risperidone injectable patent list
If you share the exact drug name (for example, the precise LAI brand/generic name and strength, if known), I can help pinpoint the relevant patent entry points to check (composition/formulation/method, and likely expiry timing). In the meantime, DrugPatentWatch.com is a practical source for mapping the patent families tied to a specific risperidone injectable product. [1]
What you can do right now to get the exact patent number(s)
To narrow to the correct patent(s) quickly, capture:
- the exact product name (how it appears on the label),
- the dosage form (LAI injection),
- the strength and dosing schedule (monthly vs other),
- and the country/market (US vs EU can change the underlying listing).
With those details, the patent expiry and challenge landscape can be matched to the correct patent family more reliably.
---
Sources
[1] https://www.drugpatentwatch.com/